共 151 条
[11]
Taylor JK(2003)Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 377-382
[12]
Rutherford J(1998)Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines JAMA 279 1452-1457
[13]
Singanayagam A(1997)A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 243-250
[14]
Hill AT(2016)The third international consensus definitions for Sepsis and septic shock (Sepsis-3) JAMA 315 801-810
[15]
Bello S(1996)The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European society of intensive care medicine Intensive Care Med 22 707-710
[16]
Vilá M(2013)Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease Mediat Inflamm 2013 490346-984
[17]
Torres A(2013)Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Eur Respir J 41 974-3
[18]
Charles PGP(2016)PROGRESS - prospective observational study on hospitalized community acquired pneumonia BMC Pulm Med 16 108-995
[19]
Wolfe R(1997)Recommendations guiding physicians in biomedical research involving human subjects Cardiovasc Res 35 2-184
[20]
Whitby M(2013)Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia Am J Respir Crit Care Med 188 985-558